ArticleInternational journal of clinical oncology2023

Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan.

Hideki Goto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.